Source: Richard Craver, WINSTON-SALEM JOURNAL, 3/10/19
 
The polarized reaction to Dr. Scott Gottlieb’s resignation as Food and Drug Administration commissioner epitomized his nearly two-year stint atop the agency. Although Gottlieb targeted pharmaceutical manufacturers in addressing the opioid epidemic and high prescription-drug prices, it appears his leadership was known foremost nationally for how aggressively he tried to reduce youth exposure to traditional and electronic cigarettes.

For more of this story, click here.